MARKSANS
MARKSANS PHARMA LIMITED

160.2 -9.28 (-5.79%)

MARKSANS is a falling knife, continues to bleed every investor trying to catch it

23 Mar, 20265 min read

MARKSANS was among the worst performers today. On a longer term basis, investors in MARKSANS PHARMA LIMITED made +0.03% per day. Monday's performance of -5.79% was a underperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}